Pinnacle Financial Group, Inc.’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
BBA
Pinnacle Financial Group, Inc.'s ACAD Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. opened a new position in Acadia Pharmaceuticals (ACAD) in Q3 2026: 175 shares worth $3.53K. The stake represents ﹤0.01% of the portfolio and ranks #1883 among its holdings.
346 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.
- Pinnacle Financial Group, Inc. held 175 shares of Acadia Pharmaceuticals worth $3.53K as of Q3 2026.
- Acadia Pharmaceuticals was a new Pinnacle Financial Group, Inc. position in Q3 2026.
- Acadia Pharmaceuticals made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #1883 holding.
- 346 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.